Recent updates on cancer immunotherapy
Traditional cancer therapies include surgery, radiation, and chemotherapy, all of which are typically non-specific approaches. Cancer immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Cancer immunotherapy represents a standing example of precision medicine: immun...
Gespeichert in:
Veröffentlicht in: | Precision clinical medicine 2018-09, Vol.1 (2), p.65-74 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 74 |
---|---|
container_issue | 2 |
container_start_page | 65 |
container_title | Precision clinical medicine |
container_volume | 1 |
creator | Liu, Ming Guo, Fukun |
description | Traditional cancer therapies include surgery, radiation, and chemotherapy, all of which are typically non-specific approaches. Cancer immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Cancer immunotherapy represents a standing example of precision medicine: immune checkpoint inhibitors precisely target the checkpoints; tumor infiltrating lymphocytes, TCR T cells, and CAR T cells precisely kill cancer cells through tumor antigen recognition; and cancer vaccines are made from patient-derived dendritic cells, tumor cell DNA, or RNA, or oncolytic viruses, thus offering a type of personalized medicine. This review will highlight up-to-date advancement in most, if not all, of the immunotherapy strategies. |
doi_str_mv | 10.1093/pcmedi/pby011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6333045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2179424073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-e27665d4f28d8618f4cb67f1af5009322c1915be78b8d76c9426c51aaf8c77a3</originalsourceid><addsrcrecordid>eNpVkM1Lw0AQxRdRbKk9epWcxEvszn73IkjxCwqC9L5sNhsbSbJxNxH635uSWuppBubHe28eQteA7wEv6aK1tcvLRZvtMMAZmhIOIgUu4fxkn6B5jF8YYwKMMYUv0YRioSQXZIpuP5x1TZf0bW46FxPfJNY01oWkrOu-8d3WBdPurtBFYaro5oc5Q5vnp83qNV2_v7ytHteppSC71BEpBM9ZQVSuBKiC2UzIAkzB8ZCXEAtL4JmTKlO5FHbJiLAcjCmUldLQGXoYZds-Gz7bJwum0m0oaxN22ptS_7805VZ_-h8tKKWY8UHg7iAQ_HfvYqfrMlpXVaZxvo-agBw8GZZ0QNMRtcHHGFxxtAGs9-3qsV09tjvwN6fZjvRfl_QXJaF3iQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2179424073</pqid></control><display><type>article</type><title>Recent updates on cancer immunotherapy</title><source>DOAJ Directory of Open Access Journals</source><source>Oxford Journals Open Access Collection</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Liu, Ming ; Guo, Fukun</creator><creatorcontrib>Liu, Ming ; Guo, Fukun</creatorcontrib><description>Traditional cancer therapies include surgery, radiation, and chemotherapy, all of which are typically non-specific approaches. Cancer immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Cancer immunotherapy represents a standing example of precision medicine: immune checkpoint inhibitors precisely target the checkpoints; tumor infiltrating lymphocytes, TCR T cells, and CAR T cells precisely kill cancer cells through tumor antigen recognition; and cancer vaccines are made from patient-derived dendritic cells, tumor cell DNA, or RNA, or oncolytic viruses, thus offering a type of personalized medicine. This review will highlight up-to-date advancement in most, if not all, of the immunotherapy strategies.</description><identifier>ISSN: 2516-1571</identifier><identifier>ISSN: 2096-5303</identifier><identifier>EISSN: 2516-1571</identifier><identifier>DOI: 10.1093/pcmedi/pby011</identifier><identifier>PMID: 30687562</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Review</subject><ispartof>Precision clinical medicine, 2018-09, Vol.1 (2), p.65-74</ispartof><rights>The Author(s) [2018]. Published by Oxford University Press on behalf of West China School of Medicine & West China Hospital of Sichuan University. 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-e27665d4f28d8618f4cb67f1af5009322c1915be78b8d76c9426c51aaf8c77a3</citedby><cites>FETCH-LOGICAL-c317t-e27665d4f28d8618f4cb67f1af5009322c1915be78b8d76c9426c51aaf8c77a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333045/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333045/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30687562$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Ming</creatorcontrib><creatorcontrib>Guo, Fukun</creatorcontrib><title>Recent updates on cancer immunotherapy</title><title>Precision clinical medicine</title><addtitle>Precis Clin Med</addtitle><description>Traditional cancer therapies include surgery, radiation, and chemotherapy, all of which are typically non-specific approaches. Cancer immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Cancer immunotherapy represents a standing example of precision medicine: immune checkpoint inhibitors precisely target the checkpoints; tumor infiltrating lymphocytes, TCR T cells, and CAR T cells precisely kill cancer cells through tumor antigen recognition; and cancer vaccines are made from patient-derived dendritic cells, tumor cell DNA, or RNA, or oncolytic viruses, thus offering a type of personalized medicine. This review will highlight up-to-date advancement in most, if not all, of the immunotherapy strategies.</description><subject>Review</subject><issn>2516-1571</issn><issn>2096-5303</issn><issn>2516-1571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpVkM1Lw0AQxRdRbKk9epWcxEvszn73IkjxCwqC9L5sNhsbSbJxNxH635uSWuppBubHe28eQteA7wEv6aK1tcvLRZvtMMAZmhIOIgUu4fxkn6B5jF8YYwKMMYUv0YRioSQXZIpuP5x1TZf0bW46FxPfJNY01oWkrOu-8d3WBdPurtBFYaro5oc5Q5vnp83qNV2_v7ytHteppSC71BEpBM9ZQVSuBKiC2UzIAkzB8ZCXEAtL4JmTKlO5FHbJiLAcjCmUldLQGXoYZds-Gz7bJwum0m0oaxN22ptS_7805VZ_-h8tKKWY8UHg7iAQ_HfvYqfrMlpXVaZxvo-agBw8GZZ0QNMRtcHHGFxxtAGs9-3qsV09tjvwN6fZjvRfl_QXJaF3iQ</recordid><startdate>201809</startdate><enddate>201809</enddate><creator>Liu, Ming</creator><creator>Guo, Fukun</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201809</creationdate><title>Recent updates on cancer immunotherapy</title><author>Liu, Ming ; Guo, Fukun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-e27665d4f28d8618f4cb67f1af5009322c1915be78b8d76c9426c51aaf8c77a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Ming</creatorcontrib><creatorcontrib>Guo, Fukun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Precision clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Ming</au><au>Guo, Fukun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent updates on cancer immunotherapy</atitle><jtitle>Precision clinical medicine</jtitle><addtitle>Precis Clin Med</addtitle><date>2018-09</date><risdate>2018</risdate><volume>1</volume><issue>2</issue><spage>65</spage><epage>74</epage><pages>65-74</pages><issn>2516-1571</issn><issn>2096-5303</issn><eissn>2516-1571</eissn><abstract>Traditional cancer therapies include surgery, radiation, and chemotherapy, all of which are typically non-specific approaches. Cancer immunotherapy is a type of cancer treatment that helps the immune system fight cancer. Cancer immunotherapy represents a standing example of precision medicine: immune checkpoint inhibitors precisely target the checkpoints; tumor infiltrating lymphocytes, TCR T cells, and CAR T cells precisely kill cancer cells through tumor antigen recognition; and cancer vaccines are made from patient-derived dendritic cells, tumor cell DNA, or RNA, or oncolytic viruses, thus offering a type of personalized medicine. This review will highlight up-to-date advancement in most, if not all, of the immunotherapy strategies.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>30687562</pmid><doi>10.1093/pcmedi/pby011</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2516-1571 |
ispartof | Precision clinical medicine, 2018-09, Vol.1 (2), p.65-74 |
issn | 2516-1571 2096-5303 2516-1571 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6333045 |
source | DOAJ Directory of Open Access Journals; Oxford Journals Open Access Collection; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | Review |
title | Recent updates on cancer immunotherapy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T13%3A36%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20updates%20on%20cancer%20immunotherapy&rft.jtitle=Precision%20clinical%20medicine&rft.au=Liu,%20Ming&rft.date=2018-09&rft.volume=1&rft.issue=2&rft.spage=65&rft.epage=74&rft.pages=65-74&rft.issn=2516-1571&rft.eissn=2516-1571&rft_id=info:doi/10.1093/pcmedi/pby011&rft_dat=%3Cproquest_pubme%3E2179424073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2179424073&rft_id=info:pmid/30687562&rfr_iscdi=true |